> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss BLA for Type 1 Diabetes
- URL: https://www.fdaweb.com/panel-to-discuss-bla-for-type-1-diabetes/
- Published: 2021-03-31T12:00:00.000Z
- Updated: 2026-09-14T16:53:08.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149004

*Federal Register* notice: FDA has announced a 5/27 Endocrinologic and Metabolic Drugs Advisory Committee meeting. Panel members are scheduled to discuss the safety and efficacy of a Provention Bio BLA for teplizumab intravenous infusion, indicated for the delay or prevention of clinical Type 1 diabetes mellitus in at-risk (Stage 2) individuals. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-06708.pdf?ref=fdaweb.com).